RISK FACTORS FOR VANCOMYCIN-INDUCED ACUTE RENAL FAILURE
- At: 2015 FIP Congress in Düsseldorf (Germany)
- Type: Poster
- By: KANG, Cindy (Lin-Shin Medical Corporation Lin-Shin Hospital, Taichung City Pharmacists Association, Pharmacy, Kaohsiung, China Taiwan)
- Co-author(s): Ying-Ying Ying-Ying Kang
Vancomycin is efficacious for MRSA infection. Due to its nephrotoxicity, however, TDM and dosage adjustment are necessary to prevent ARF. Peak and trough level measurements require blood tests, during which patients may feel some discomfort. Thus, one should only conduct blood tests only when needed to minimise medical resource waste.
We observed.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.